Research

The study provides the first nationwide look at who knows about, carries and uses the opioid overdose reversal drug naloxone, which became available over the counter in 2023.

A two-pronged reform strategy can limit the competitive edge for Medicare Advantage plans that aggressively upcode while lowering overpayments.